English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 78 | Tables: 74 | Medical Care
The global market for Subcutaneous Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
North American market for Subcutaneous Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Subcutaneous Immunotherapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Subcutaneous Immunotherapy in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Subcutaneous Immunotherapy include Anergis, HAL Allergy Group, Merck, Allergy Therapeutics, ALK-Abello, Stallergenes Greer, Laboratorios LETI, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Immunotherapy.
The Subcutaneous Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
Segment by Type
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Asthma
1.2.3 Allergic Rhinitis
1.2.4 Venom Allergy
1.2.5 Food Allergy
1.3 Market by Application
1.3.1 Global Subcutaneous Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Subcutaneous Immunotherapy Market Perspective (2020-2031)
2.2 Global Subcutaneous Immunotherapy Growth Trends by Region
2.2.1 Global Subcutaneous Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Subcutaneous Immunotherapy Historic Market Size by Region (2020-2025)
2.2.3 Subcutaneous Immunotherapy Forecasted Market Size by Region (2026-2031)
2.3 Subcutaneous Immunotherapy Market Dynamics
2.3.1 Subcutaneous Immunotherapy Industry Trends
2.3.2 Subcutaneous Immunotherapy Market Drivers
2.3.3 Subcutaneous Immunotherapy Market Challenges
2.3.4 Subcutaneous Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Subcutaneous Immunotherapy Players by Revenue
3.1.1 Global Top Subcutaneous Immunotherapy Players by Revenue (2020-2025)
3.1.2 Global Subcutaneous Immunotherapy Revenue Market Share by Players (2020-2025)
3.2 Global Subcutaneous Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Subcutaneous Immunotherapy Revenue
3.4 Global Subcutaneous Immunotherapy Market Concentration Ratio
3.4.1 Global Subcutaneous Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Immunotherapy Revenue in 2024
3.5 Global Key Players of Subcutaneous Immunotherapy Head office and Area Served
3.6 Global Key Players of Subcutaneous Immunotherapy, Product and Application
3.7 Global Key Players of Subcutaneous Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Immunotherapy Breakdown Data by Type
4.1 Global Subcutaneous Immunotherapy Historic Market Size by Type (2020-2025)
4.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Type (2026-2031)
5 Subcutaneous Immunotherapy Breakdown Data by Application
5.1 Global Subcutaneous Immunotherapy Historic Market Size by Application (2020-2025)
5.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Subcutaneous Immunotherapy Market Size (2020-2031)
6.2 North America Subcutaneous Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Subcutaneous Immunotherapy Market Size by Country (2020-2025)
6.4 North America Subcutaneous Immunotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Subcutaneous Immunotherapy Market Size (2020-2031)
7.2 Europe Subcutaneous Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Subcutaneous Immunotherapy Market Size by Country (2020-2025)
7.4 Europe Subcutaneous Immunotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Immunotherapy Market Size (2020-2031)
8.2 Asia-Pacific Subcutaneous Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Subcutaneous Immunotherapy Market Size (2020-2031)
9.2 Latin America Subcutaneous Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Subcutaneous Immunotherapy Market Size by Country (2020-2025)
9.4 Latin America Subcutaneous Immunotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Immunotherapy Market Size (2020-2031)
10.2 Middle East & Africa Subcutaneous Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anergis
11.1.1 Anergis Company Details
11.1.2 Anergis Business Overview
11.1.3 Anergis Subcutaneous Immunotherapy Introduction
11.1.4 Anergis Revenue in Subcutaneous Immunotherapy Business (2020-2025)
11.1.5 Anergis Recent Development
11.2 HAL Allergy Group
11.2.1 HAL Allergy Group Company Details
11.2.2 HAL Allergy Group Business Overview
11.2.3 HAL Allergy Group Subcutaneous Immunotherapy Introduction
11.2.4 HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2020-2025)
11.2.5 HAL Allergy Group Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Subcutaneous Immunotherapy Introduction
11.3.4 Merck Revenue in Subcutaneous Immunotherapy Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Company Details
11.4.2 Allergy Therapeutics Business Overview
11.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Introduction
11.4.4 Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2020-2025)
11.4.5 Allergy Therapeutics Recent Development
11.5 ALK-Abello
11.5.1 ALK-Abello Company Details
11.5.2 ALK-Abello Business Overview
11.5.3 ALK-Abello Subcutaneous Immunotherapy Introduction
11.5.4 ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2020-2025)
11.5.5 ALK-Abello Recent Development
11.6 Stallergenes Greer
11.6.1 Stallergenes Greer Company Details
11.6.2 Stallergenes Greer Business Overview
11.6.3 Stallergenes Greer Subcutaneous Immunotherapy Introduction
11.6.4 Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2020-2025)
11.6.5 Stallergenes Greer Recent Development
11.7 Laboratorios LETI
11.7.1 Laboratorios LETI Company Details
11.7.2 Laboratorios LETI Business Overview
11.7.3 Laboratorios LETI Subcutaneous Immunotherapy Introduction
11.7.4 Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2020-2025)
11.7.5 Laboratorios LETI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Subcutaneous Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Asthma
Table 3. Key Players of Allergic Rhinitis
Table 4. Key Players of Venom Allergy
Table 5. Key Players of Food Allergy
Table 6. Global Subcutaneous Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Subcutaneous Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Subcutaneous Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Subcutaneous Immunotherapy Market Share by Region (2020-2025)
Table 10. Global Subcutaneous Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Subcutaneous Immunotherapy Market Share by Region (2026-2031)
Table 12. Subcutaneous Immunotherapy Market Trends
Table 13. Subcutaneous Immunotherapy Market Drivers
Table 14. Subcutaneous Immunotherapy Market Challenges
Table 15. Subcutaneous Immunotherapy Market Restraints
Table 16. Global Subcutaneous Immunotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Subcutaneous Immunotherapy Market Share by Players (2020-2025)
Table 18. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunotherapy as of 2024)
Table 19. Ranking of Global Top Subcutaneous Immunotherapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Subcutaneous Immunotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Subcutaneous Immunotherapy, Headquarters and Area Served
Table 22. Global Key Players of Subcutaneous Immunotherapy, Product and Application
Table 23. Global Key Players of Subcutaneous Immunotherapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Subcutaneous Immunotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Subcutaneous Immunotherapy Revenue Market Share by Type (2020-2025)
Table 27. Global Subcutaneous Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Subcutaneous Immunotherapy Revenue Market Share by Type (2026-2031)
Table 29. Global Subcutaneous Immunotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Subcutaneous Immunotherapy Revenue Market Share by Application (2020-2025)
Table 31. Global Subcutaneous Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Subcutaneous Immunotherapy Revenue Market Share by Application (2026-2031)
Table 33. North America Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Subcutaneous Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Subcutaneous Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Subcutaneous Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Subcutaneous Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Subcutaneous Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Subcutaneous Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Subcutaneous Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. Anergis Company Details
Table 49. Anergis Business Overview
Table 50. Anergis Subcutaneous Immunotherapy Product
Table 51. Anergis Revenue in Subcutaneous Immunotherapy Business (2020-2025) & (US$ Million)
Table 52. Anergis Recent Development
Table 53. HAL Allergy Group Company Details
Table 54. HAL Allergy Group Business Overview
Table 55. HAL Allergy Group Subcutaneous Immunotherapy Product
Table 56. HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2020-2025) & (US$ Million)
Table 57. HAL Allergy Group Recent Development
Table 58. Merck Company Details
Table 59. Merck Business Overview
Table 60. Merck Subcutaneous Immunotherapy Product
Table 61. Merck Revenue in Subcutaneous Immunotherapy Business (2020-2025) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Allergy Therapeutics Company Details
Table 64. Allergy Therapeutics Business Overview
Table 65. Allergy Therapeutics Subcutaneous Immunotherapy Product
Table 66. Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2020-2025) & (US$ Million)
Table 67. Allergy Therapeutics Recent Development
Table 68. ALK-Abello Company Details
Table 69. ALK-Abello Business Overview
Table 70. ALK-Abello Subcutaneous Immunotherapy Product
Table 71. ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2020-2025) & (US$ Million)
Table 72. ALK-Abello Recent Development
Table 73. Stallergenes Greer Company Details
Table 74. Stallergenes Greer Business Overview
Table 75. Stallergenes Greer Subcutaneous Immunotherapy Product
Table 76. Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2020-2025) & (US$ Million)
Table 77. Stallergenes Greer Recent Development
Table 78. Laboratorios LETI Company Details
Table 79. Laboratorios LETI Business Overview
Table 80. Laboratorios LETI Subcutaneous Immunotherapy Product
Table 81. Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2020-2025) & (US$ Million)
Table 82. Laboratorios LETI Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Subcutaneous Immunotherapy Picture
Figure 2. Global Subcutaneous Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Subcutaneous Immunotherapy Market Share by Type: 2024 VS 2031
Figure 4. Asthma Features
Figure 5. Allergic Rhinitis Features
Figure 6. Venom Allergy Features
Figure 7. Food Allergy Features
Figure 8. Global Subcutaneous Immunotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Subcutaneous Immunotherapy Market Share by Application: 2024 VS 2031
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Subcutaneous Immunotherapy Report Years Considered
Figure 14. Global Subcutaneous Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Subcutaneous Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Subcutaneous Immunotherapy Market Share by Region: 2024 VS 2031
Figure 17. Global Subcutaneous Immunotherapy Market Share by Players in 2024
Figure 18. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunotherapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Subcutaneous Immunotherapy Revenue in 2024
Figure 20. North America Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Subcutaneous Immunotherapy Market Share by Country (2020-2031)
Figure 22. United States Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Subcutaneous Immunotherapy Market Share by Country (2020-2031)
Figure 26. Germany Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Subcutaneous Immunotherapy Market Share by Region (2020-2031)
Figure 34. China Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Subcutaneous Immunotherapy Market Share by Country (2020-2031)
Figure 42. Mexico Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Subcutaneous Immunotherapy Market Share by Country (2020-2031)
Figure 46. Turkey Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Subcutaneous Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Anergis Revenue Growth Rate in Subcutaneous Immunotherapy Business (2020-2025)
Figure 50. HAL Allergy Group Revenue Growth Rate in Subcutaneous Immunotherapy Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Subcutaneous Immunotherapy Business (2020-2025)
Figure 52. Allergy Therapeutics Revenue Growth Rate in Subcutaneous Immunotherapy Business (2020-2025)
Figure 53. ALK-Abello Revenue Growth Rate in Subcutaneous Immunotherapy Business (2020-2025)
Figure 54. Stallergenes Greer Revenue Growth Rate in Subcutaneous Immunotherapy Business (2020-2025)
Figure 55. Laboratorios LETI Revenue Growth Rate in Subcutaneous Immunotherapy Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
